Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Current-Deferred-Revenue" stands at 6.05 Billion Japanese Yens as of 06/30/2024, the lowest value since 06/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -63.29 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -63.29 Billion Japanese Yens.
The 3 year change is -58.78 Billion Japanese Yens.
The 5 year change is -63.48 Billion Japanese Yens.
The 10 year change is -13.46 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |